(TTI) Tetra Technologies - Overview
Stock: Completion Fluids, Additives, Calcium Chloride, Zinc Bromide, Water Management
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 62.2% |
| Relative Tail Risk | -6.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.86 |
| Alpha | 145.54 |
| Character TTM | |
|---|---|
| Beta | 1.508 |
| Beta Downside | 2.416 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.43% |
| CAGR/Max DD | 0.65 |
Description: TTI Tetra Technologies December 27, 2025
Tetra Technologies Inc. (NYSE:TTI) operates as an energy-services firm through two primary segments. The Completion Fluids & Products segment manufactures clear brine fluids, additives, calcium-chloride products, and ultra-pure zinc-bromide for oil-field drilling, completion, workover operations, and battery-technology applications worldwide. The Water & Flowback Services segment delivers on-site water-management, frac-flowback, and production-well testing services to onshore operators across the United States and multiple international basins.
Key recent metrics indicate the company generated approximately $1.2 billion in revenue for FY 2023, with an adjusted EBITDA margin near 12% and a backlog of roughly $300 million, reflecting steady demand for completion fluids amid a rebound in U.S. drilling activity. The segment’s performance is highly sensitive to crude-oil price trends and the U.S. rig count, both of which drive well-completion volumes. Additionally, the growing market for zinc-bromide in battery storage aligns TTI with the broader clean-energy transition, offering a potential secular growth catalyst.
For a deeper quantitative dive, the ValueRay platform provides a granular view of TTI’s valuation metrics and peer comparisons, which can help you assess the investment thesis more rigorously.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 122.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 1.73 > 1.0 |
| NWC/Revenue: 29.19% < 20% (prev 25.76%; Δ 3.43% < -1%) |
| CFO/TA 0.11 > 3% & CFO 74.3m > Net Income 122.2m |
| Net Debt (147.4m) to EBITDA (95.8m): 1.54 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (134.8m) vs 12m ago 2.13% < -2% |
| Gross Margin: 25.64% > 18% (prev 0.22%; Δ 2542 % > 0.5%) |
| Asset Turnover: 107.0% > 50% (prev 123.3%; Δ -16.24% > 0%) |
| Interest Coverage Ratio: 3.15 > 6 (EBITDA TTM 95.8m / Interest Expense TTM 18.6m) |
Altman Z'' 1.22
| A: 0.28 (Total Current Assets 313.9m - Total Current Liabilities 133.3m) / Total Assets 655.2m |
| B: -0.23 (Retained Earnings -148.9m / Total Assets 655.2m) |
| C: 0.10 (EBIT TTM 58.6m / Avg Total Assets 578.2m) |
| D: -0.50 (Book Value of Equity -179.5m / Total Liabilities 359.7m) |
| Altman-Z'' Score: 1.22 = BB |
Beneish M -2.63
| DSRI: 1.06 (Receivables 116.4m/110.0m, Revenue 618.8m/617.7m) |
| GMI: 0.86 (GM 25.64% / 22.01%) |
| AQI: 1.67 (AQ_t 0.21 / AQ_t-1 0.13) |
| SGI: 1.00 (Revenue 618.8m / 617.7m) |
| TATA: 0.07 (NI 122.2m - CFO 74.3m) / TA 655.2m) |
| Beneish M-Score: -2.63 (Cap -4..+1) = A |
What is the price of TTI shares?
Over the past week, the price has changed by +2.37%, over one month by +19.94%, over three months by +56.43% and over the past year by +173.30%.
Is TTI a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.8 | 9.3% |
| Analysts Target Price | 12.8 | 9.3% |
| ValueRay Target Price | 14.3 | 22.4% |
TTI Fundamental Data Overview February 07, 2026
P/S = 2.5225
P/B = 4.9994
P/EG = 0.2
Revenue TTM = 618.8m USD
EBIT TTM = 58.6m USD
EBITDA TTM = 95.8m USD
Long Term Debt = 180.9m USD (from longTermDebt, last quarter)
Short Term Debt = 10.6m USD (from shortTermDebt, last quarter)
Debt = 214.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 147.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.71b USD (1.56b + Debt 214.6m - CCE 67.1m)
Interest Coverage Ratio = 3.15 (Ebit TTM 58.6m / Interest Expense TTM 18.6m)
EV/FCF = 275.6x (Enterprise Value 1.71b / FCF TTM 6.20m)
FCF Yield = 0.36% (FCF TTM 6.20m / Enterprise Value 1.71b)
FCF Margin = 1.00% (FCF TTM 6.20m / Revenue TTM 618.8m)
Net Margin = 19.75% (Net Income TTM 122.2m / Revenue TTM 618.8m)
Gross Margin = 25.64% ((Revenue TTM 618.8m - Cost of Revenue TTM 460.1m) / Revenue TTM)
Gross Margin QoQ = 23.73% (prev 27.75%)
Tobins Q-Ratio = 2.61 (Enterprise Value 1.71b / Total Assets 655.2m)
Interest Expense / Debt = 2.07% (Interest Expense 4.45m / Debt 214.6m)
Taxrate = 48.78% (3.95m / 8.11m)
NOPAT = 30.0m (EBIT 58.6m * (1 - 48.78%))
Current Ratio = 2.35 (Total Current Assets 313.9m / Total Current Liabilities 133.3m)
Debt / Equity = 0.72 (Debt 214.6m / totalStockholderEquity, last quarter 296.7m)
Debt / EBITDA = 1.54 (Net Debt 147.4m / EBITDA 95.8m)
Debt / FCF = 23.78 (Net Debt 147.4m / FCF TTM 6.20m)
Total Stockholder Equity = 278.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.14% (Net Income 122.2m / Total Assets 655.2m)
RoE = 43.84% (Net Income TTM 122.2m / Total Stockholder Equity 278.8m)
RoCE = 12.75% (EBIT 58.6m / Capital Employed (Equity 278.8m + L.T.Debt 180.9m))
RoIC = 6.54% (NOPAT 30.0m / Invested Capital 459.1m)
WACC = 10.21% (E(1.56b)/V(1.78b) * Re(11.47%) + D(214.6m)/V(1.78b) * Rd(2.07%) * (1-Tc(0.49)))
Discount Rate = 11.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.81%
[DCF Debug] Terminal Value 60.95% ; FCFF base≈6.20m ; Y1≈4.07m ; Y5≈1.86m
Fair Price DCF = N/A (negative equity: EV 26.4m - Net Debt 147.4m = -121.0m; debt exceeds intrinsic value)
EPS Correlation: 1.38 | EPS CAGR: -50.84% | SUE: -1.03 | # QB: 0
Revenue Correlation: 59.14 | Revenue CAGR: 8.42% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.27 | Chg30d=-0.013 | Revisions Net=-1 | Growth EPS=+17.6% | Growth Revenue=+4.0%